“…Considering the multitude of functions played by the striatum, MSNs are the target not only of dopamine, but also other endogenous G-protein-regulating neuromodulators, such as serotonin, cannabinoids, adenosine, and opioids, since the control of many functions is dependent on multiple synchronized ligand actions (Augusto et al, 2013;Araque et al, 2017;Cavaccini et al, 2018;Nummenmaa et al, 2018). The malfunction of this intricate machinery translates into several striatum-related pathologies, such as addiction, Huntington's disease, Parkinson's disease, depression, and schizophrenia, among others (Li et al, 2015;Florio et al, 2018;Rivas-Grajales et al, 2018). It is still debatable how GPCRs fine-tune the signaling between the binding of certain neuromodulators and the subsequent molecular mechanisms.…”